Catalyst

Slingshot members are tracking this event:

FDA Grants Fast Track Designation for Astellas (ALPMY) and Immunomic Therapeutics' ASP0892 for the Mitigation of Severe Hypersensitivity Reactions due to Peanut Allergy

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ALPMY

100%
Immunomic Therapeutics

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 20, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Fda, Fast Track Review, Asp0892, Severe Hypersensitivity, Peanut Allergies